Eliaz P. Babaev, Ph.D., Co-Founded Arobella Medical, LLC in 2006 and serves as its Chief Executive Officer and President. Dr. Babaev Co-founded Celleration Inc. and served as its Chief Technical Officer until July 2009 and Chief Executive Officer. Dr. Babaev worked as an ultrasound system design engineer and research scientist for DiaSorin, Inc., SpectRx, and AeroPag-USA, Inc. He served as the Head of Biomedical Engineering Laboratory and a Professor for State Technical University, Baku, USSR for 25 years. Dr. Babaev then immigrated to the U.S. in 1994 and worked as a senior technical consultant for several medical device companies. He served as Assistant Professor in the Biomedical Engineering Department of Bauman Moscow State Technical University. He has also been a Research Fellow in Biomechanics and Bioengineering at the Warsaw University of Technology and Bulgarian Academy of Sciences. Dr. Babaev graduated from Moscow-Bauman Technical University with a Ph.D. in Biomedical Engineering and Biomechanical Engineering in 1975. Dr. Babaev holds D.Sc. (Doctor of Science), Biomedical Engineering (Medical Ultrasound) in 1993 and D.Sc., Biomedical Instrumentations and Biomechanics from Latvian Academy of Science, Center For Biomechanics & Biomedical Engineering Riga, Latvia in 1991. He received B.S. and M.S. Degree in Mechanical Engineering (Industrial Ultrasound - NDT for Oil Reservoirs) in Azerbaijan Technical University Baku, Azerbaijan in 1969. Dr. Babaev has more than 40+ years expertise in Non-Imaging Medical Ultrasound and particularly in Ultrasound Wound Management, live tissue repair and in all the areas of advances in skin, wound care, nursing, tissue science, drug delivery systems, wound treatment technologies, tissue engineering, and body architectonics research and cancer research including apoptosis. 50+ US and 100+ Worldwide Patents are issued, numerous are pending, 50+ scientific articles, abstracts are published.
Ultrasound Wound Management, live tissue repair and in all the areas of advances in skin, wound care, nursing, tissue science, drug delivery systems, wound treatment technologies, tissue engineering, and body architectonics research and cancer research including apoptosis.
Jasmina Begic is a Medical Consultant for BIOPTRON, Zepter Internastional for Bosnia and Herzegovina, Founder of Association for Wound management in B&H, Founder and author of Euro-Asian Forum, one of founder of www.BALWMA.org. She is currently working as a Dermatovenerologyst in Bioptron International team-Wound Healing and also a certified VCC trainer of elderly care; certified VCC trainer of manager EU founds; certified practitioner of TCM; certified practitioner of herbal medicine. She finished her graduation and post-graduation studies at Medical School of University Sarajevo, Sarajevo, Bosnia and Herzegovina and completed her PhD in the field of Tissue Regeneration and Wound Healing from Indian Institute of Technology, Kharagpur. She did volunteer works in Association for Wound management in Bosnia and Herzegovina (AWMinB&H) from 2008 till present. She is also active member in UEMS TF WH, EWMA, EADV. Her projects are involved in Clinical Research “Appliance Bioptron polarized light (480 -3400nm) in the therapy of dermatosis: Acne vulgaris and Ulcer cruris” which is approved by members of Scientifically Research Institute of Clinical Center of University in Sarajevo and Members of Ethics Commitee of Clinical Center University in Sarajevo; Euro-Asian Forum of Association for Wound Management (2011, 2012, 2014, 2016, 2018); Academy for health and social occupation (2013); Implementation of Traditional Chinese Medicine in health and stationary institution in Bosnia and Herzegovina and country of Western Balkan (2014); Balkan Wound Management Association (2015); Integrative Medicine in Postoperative Management (2017); Integrative medicine: Prevention is best cure of Pressure Ulcers (2017).
Chronic Wounds, Leg ulcers different etiology, Disorders of sebacious glands (Acne vulgaris, Rosacea), Anti-Aging Treatments (Non-Invasive Treatments).
Joseph Krieger offers over 25-years of healthcare experience and 10-years of laboratory science background in biochemistry. Joseph was educated at Boston University School of Medicine, and is a graduate of University of Massachusetts, Amherst. He has holded positions such as President of Interventional Pain Management Techniques, Business development Director in Cedara Software and Sales Manager and Director in Radionics. Joseph’s experience includes management, product management, sales and marketing, regulatory affairs, minimally invasive surgery, image guided surgical navigation, medical imaging, software imaging for medical technologies and minimally invasive surgical devices. Joseph has created and executed hundreds of hands-on training programs for physicians and healthcare professionals in various medical markets. Several of these markets include Interventional Pain Management. Joseph is currently the President, Boston BioLife, which creates hands-on training and education programs in translational medicine for healthcare physicians, including stem cells and biologics in musculoskeletal medicine.
Biochemistry, Pain Management, Medical Imaging
Matthew J Regulski is the director of the wound institute of ocean county NJ and Senior partner with ocean county foot and ankle surgical associates. He is also board of directors of the international federation of podiatric educators. He was triple board-certified member. He has been pi on 12 RCT’s. he has published multiple articles in peer reviewed journals and authored chapters in surgical texts. He acts as a reviewer for 6 peer reviewed journals and the associate editor for the Journal of Dermatology and Cosmetology. He treats over 6, ooo chronic wounds in a year.
Cristian Nicoletti offers over 10 years in Casa di Cura Pederzoli as Director of Diabetic Foot Unit. He specialized in diabetology in 2004, and then perfected himself in the treatment of diabetic foot, an activity that he currently does so diligently. He started his career at the University of Verona, where he worked for several years, then to continue in a clinic in Vicenza specialized in the treatment of diabetic foot. Since 2008, he has been in charge of the operating unit of the diabetic foot at the nursing home "Dott. Pederzoli "of Peschiera del Garda. He completed his degree in in medicine and surgery from Università degli Studi di Milano and graduation specialization in Endocrinology and Metabolism Diseases from Università degli Studi di Milano and Diploma from Liceo Scientifico Blaise Pascal, Milano. He has more than 20 journal publications.
Andrea Bellingeri, born in Pavia in 27/6/61 where he currently lives. He is the Founder of AISLeC (Italian nursing association on wound management) and President from 1994 to 2004. He works in Fondation IRCCS S.Matteo for more than 30 years and RN from 1986, Head Nurse in Ambulatory Service on Wound Care for past 10 years. He presented posters and presentations in meeting and courses over 250; wrote 14 chapters or books; 11 articles and attended as coordinator in 15 nursing research (6 of them were multicenter). He was winner session on EWMA Meeting in the research of 1996; winner on meeting of Italian Society of Quality on 1997; the research of 2015 was winner session JWC AWARDS in 2018 on field pre-clinical; Teacher in over 26 University courses on wound-care and EPUAP Trustees from 2001 to 2008.
Intensive Care, Ambulatory Service on Wound Care
Ernesto Delgado Cidranes is Spanish Anesthesiologist, Director, CEO & Founder at Advanced Pain & Aesthetic Management Center Madrid and Editorial Board Member of Journal of Pain Management and Therapy. He is also AIUM Member, Reviewer and Advisor of Journal of Ultrasound in Medicine, American Institute, USA; Chairman of Department of Anesthesia and Pain Medicine, Spanish University Health Ministry; Professor of Advanced Ultrasound and Founder at Advanced Pain Management Center Madrid. He has an integrative and interdisciplinary concept in the treatment of pain.
Dr. Osorio is a innovative businessman with an distinct entrepreneurial mindset concentrated in adding value on the areas of Biotechnology (mRNA), Reprogramming & Regenerative Medicine for translational use in humans and a variety of clinical applications aimed for both the private and the public health sectors. He is the CEO of RegenerAge Clinic and RegenerAge Beauty. VP and Clinical Developer for Bioquark, Inc., CCO at Reanima Advance Biosciences Project. President at Dr. Jois an anti-aging, beauty, and cosmetic products endorsement company. VP and Chairman of the WAMS Americas Division. Earned MD degree at Westhill University. Diplomate in aesthetic medicine (UAG), Advance Fellow by the ABAARM, visiting scholar at UNC at Chapel Hill in Dermatology. Fellow in Stem Cell Medicine by the A4M and USF, Business Diplomate at ECA, enrolled Master on Health Sciences at Victoria University. Has appeared on several occasions on International media, some of his latest broadcast appearances are CNN español, TV Azteca, Excelsior Newspaper, Medicable, PharmaBoard Room, and Podcasts among others. His public appearances as a speaker at the 2018 RAADfest (San Diego), 3rd International Conference on Molecular Medicine and Diagnostics (Dubai), Global Academic Business Forum on Tissue Engineering and Regenerative Medicine (Baltimore), Second International Congress on mHealth (Shiraz), 6th International Conference on Tissue Engineering and Regenerative Medicine (S.F), 11th World Congress on Cell & Tissue Science (Tokyo), 17th International Conference on Neurology and Neuroscience (Toronto), 9th International Conference & Exhibition on Tissue Science and Regenerative Medicine (Las Vegas) among others, makes him a pioneer on the Regenerative+Reprogramming Medicine Field. His passion for football, brought as a result the Dr.Jois Foundation A.C aimed at helping those American football athletes who have sustained injury get another chance through the Regenerative & Reprogramming Medicine.
Hiroko Tadaura is currently working in Graduate School of Nursing and Rehabilitation Science in International University Health and Welfare Graduate School, Tokyo, Japan. Professor. Dr. Hiroko is also working as part-time Professor at Graduate School of Medicine, Tohoku University, Miyagi, Japan. She did research as guest researcher in School of Nursing Science in University of Witten/Herdecke, Witten, Germany in 2008- 2011; senior guest researcher in School of Nursing Science in University of Witten/ Herdecke,Witten, Germany in 2012-2015. She graduated from Tohoku University Graduate School of Medicine (Ph.D. in Medicine). A Member of European Kinaesthetics Association, German Branch. IOS New Scholar Award of Self-Care Dependent-Care Nursing, International Orem Society, USA in 2014.
Shaik O. Rahaman, PhD, is an Assistant Professor at the University of Maryland, USA. His laboratory is interested in elucidating the signaling events underlying the pathogenesis of atherosclerosis and fibrosis. Dr. Rahaman earned his PhD in Molecular Biology at Jadavpur University, and a BS in Human Physiology (Honors), and an MS in Biophysics and Molecular Biology from University of Calcutta. From 2000-2014, Dr. Rahaman worked at Cleveland Clinic, Cleveland, USA, as a Postdoctoral Fellow, eventually as a Project Scientist and Assistant Professor. He was the recipient of the American Heart Association Scientist Development Grant, NIH-R01 grant, and NSF grant. Dr. Rahaman is the author or co-author of 23 research papers in high impact international peer-reviewed journals of repute. Dr. Rahaman has given numerous invited talks nationally and internationally, and is a reviewer/editorial board member in numerous scientific journals. Dr. Rahaman also served as a reviewer for National Institute of Health (USA).
Mr. De la Parra is an entrepreneur focused on Information Technology, Education and Health. He is creative and results-driven and has 16+ years of Digital Strategy experience in architecture and implementation. Mr. De la Parra is the COO and Co-founding Partner at The Solomon Brokerage Firm. He currently leads as CEO at Mass Media Dynamics and De la Parra Mobile Solutions and is former CEO & Founder at Astrum Salud Móvil and its Telemedicine service Astrum Móvil. Moreover, he is COO & Co-founder at RegenerAge Clinic & RegenerAge Beauty, the Digital Strategy Director & Co-founder at Dr. Jois®, BiorganicAging, What Skin Needs/WSN International Pty. Ltd. He also serves as current CMO at ReAnima Advanced Biosciences and is the Digital Media Director at Bioquark, Inc. He is also the former Latin America Region Manager and Digital Strategy adviser at CardiacSense and former CITO & Senior Partner at Cerezo Editores. Within the academic and educational fields, Mr. De la Parra acts as the Executive Vice President: Executive Chairman of the WAMS Mobile Health Division, WAMS Chief Coordinating Officer, a member of the WAMS Executive Council (WAMS Executive Board), a member of the WAMS Education & Training Board (ETB), a member of the WAMS Editorial Board, an Honorary Member of the Academy Faculty FWAMS, an Honorary Fellow of the Academy & is also a Senior Partner at WAMS, The World Academy of Medical Sciences. He also functions as the Chief Operating Officer and is a Co-founding Partner at The Reprogramming Medicine Association. Mr. De la Parra is also a member of the National Introducing Brokers Association and a part of the National Biofuel Board, (Alliance Program), also being the founder and former Board of Directors member of Astrum Fundación, an Advisory Board member of the Lifeboat Foundation, an Advisory Board member of the Future Worlds Center -Cyprus Neuroscience & Technology Institute (Senior TV Program), a Federated member of the International Longevity Alliance, and volunteered as Digital Strategy adviser at the Major Mouse Testing Program. He is also a member of the Web Committee at the Life Extension Advocacy Foundation / Lifespan.io and has volunteered with SENS Research Foundation for the OncoSENS Program in Digital Strategy.